Cheng San Brian Chia

Title: Cheng San Brian Chia: Innovator in Therapeutic Peptides

Introduction

Cheng San Brian Chia is a notable inventor based in Singapore, SG. He has made significant contributions to the field of therapeutic peptides, holding a total of 3 patents. His work focuses on innovative solutions for medical disorders, particularly those involving dysregulation of specific proteins.

Latest Patents

Chia's latest patents include groundbreaking inventions such as the Therapeutic Spalt-Like Transcription Factor 4 (SALL4) peptide. This invention describes isolated peptides and pharmaceutical compositions that bind to retinoblastoma binding protein 4 (RBBp4), effectively blocking the SALL4-RBBp4 interaction. Additionally, methods for inhibiting the binding of SALL4 to RBBp4 and treating disorders mediated by SALL4 dysregulation are also detailed. Another significant patent involves EIF4E binding peptides, which relates to modified eIF4G1 peptides and their pharmaceutical applications.

Career Highlights

Cheng San Brian Chia has worked with esteemed institutions such as the Agency for Science, Technology and Research and the National University of Singapore. His career reflects a commitment to advancing scientific knowledge and developing practical applications for his research.

Collaborations

Chia has collaborated with notable colleagues, including Christopher John Brown and Bee Hui Liu. These partnerships have likely contributed to the success and impact of his inventions.

Conclusion

Cheng San Brian Chia stands out as an innovative inventor in the field of therapeutic peptides. His contributions are paving the way for new treatments and understanding of complex medical conditions.